Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma

  • Authors:
    • Stefan Retzlaff
    • Teresa Padro
    • Peter Koch
    • Elisabeth Oelmann
    • Norbert Lugering
    • Rolf M. Mesters
    • Wolfgang E. Berdel
  • View Affiliations

  • Published online on: May 1, 2002     https://doi.org/10.3892/or.9.3.525
  • Pages: 525-527
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Tumor angiogenesis plays a significant role in cancer growth and metastasis. This complex process is influenced by a variety of angiogenic factors. Elevated serum levels or high expression of some of these factors have been shown to correlate with stage and prognosis in certain human malignancies. This has been demonstrated most consistently for vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). We tried to establish, whether pre-treatment serum levels of the angiogenic factors VEGF, bFGF, interleukin 8 (IL-8) and Flt3 ligand (Flt3L) correlate with prognostic variables in 30 patients with primary gastro-intestinal non-Hodgkin's lymphoma. Our results suggest that higher pretreatment serum levels of IL-8 and Flt3L are associated with higher stage (≥ II) and high grade, respectively. Elevated pretreatment serum levels of VEGF and bFGF were not associated with advanced disease characteristics and carried no prognostic information.

Related Articles

Journal Cover

May-June 2002
Volume 9 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Retzlaff S, Padro T, Koch P, Oelmann E, Lugering N, Mesters RM and Berdel WE: Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma. Oncol Rep 9: 525-527, 2002
APA
Retzlaff, S., Padro, T., Koch, P., Oelmann, E., Lugering, N., Mesters, R.M., & Berdel, W.E. (2002). Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma. Oncology Reports, 9, 525-527. https://doi.org/10.3892/or.9.3.525
MLA
Retzlaff, S., Padro, T., Koch, P., Oelmann, E., Lugering, N., Mesters, R. M., Berdel, W. E."Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma". Oncology Reports 9.3 (2002): 525-527.
Chicago
Retzlaff, S., Padro, T., Koch, P., Oelmann, E., Lugering, N., Mesters, R. M., Berdel, W. E."Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma". Oncology Reports 9, no. 3 (2002): 525-527. https://doi.org/10.3892/or.9.3.525